Australia's Vaxxas licenses next-gen vaccine for Respiratory Syncytial Virus from NIH
Vaccines | News | 2 Comment | 29 Oct, 2024
Australia-based Vaxxas, a clinical-stage biotechnology company commercialising a novel high-density microarray patc...Read more
SK bioscience's Quadrivalent Influenza Vaccine SKYCellflu approved in Indonesia
Vaccines | News | 0 Comment | 23 Oct, 2024
SK bioscience, a global innovator in vaccines and biotechnology, announced that Indonesia's Food and Drug Agency, BPOM (...Read more
CEPI supports advancement of open-access coronavirus vaccines R&D roadmap with $3.2 M funding
Vaccines | News | 0 Comment | 13 Oct, 2024
The Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota, US will receive $3.2 mill...Read more
Vaccines | News | 1 Comment | 10 Oct, 2024
China-based CanSino Biologics Inc. has received an additional financial boost, securing a grant exceeding $17 million to...Read more
SK bioscience invests $3 M in US-based FinaBio specialising in next-gen conjugate vaccine technology
Vaccines | News | 0 Comment | 08 Oct, 2024
South Korea-based SK bioscience has signed an agreement to acquire a stake in Fina Biosolutions, a promising R&D bio...Read more
Cenra Healthcare to promote Moderna’s mRNA respiratory vaccine portfolio in Taiwan
Vaccines | News | 0 Comment | 01 Oct, 2024
Moderna, Inc. and Cenra Healthcare, the sales and marketing arm of Cenra Inc., have entered into a joint agreement regar...Read more
Singapore HSA approves Abrysvo Vaccine by Pfizer to combat Respiratory Syncytial Virus (RSV)
Vaccines | News | 0 Comment | 25 Sep, 2024
Singapore Health Sciences Authority (HSA) has approved the Pfizer's bivalent vaccine, Abryvso, for active immu...Read more
WHO prequalifies first vaccine against mpox
Vaccines | News | 0 Comment | 16 Sep, 2024
The World Health Organization (WHO) has announced MVA-BN vaccine as the first vaccine against mpox to be added to its pr...Read more
Japan approves self-amplifying mRNA COVID-19 vaccine for protection against JN.1 strain
Vaccines | News | 0 Comment | 13 Sep, 2024
Global biotechnology leader CSL and self amplifying-mRNA pioneer Arcturus Therapeutics have announced that Japan's Minis...Read more
GSK announces launch of Herpes Zoster vaccine Shingrix in Malaysia
Vaccines | News | 0 Comment | 13 Sep, 2024
GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) has announced the launch of its Herpes Zoster vaccine, Shingrix, ...Read more
BIOCHINA 2025: China’s Largest Bio Convention to Host Over 3,000 Biotech Companies
Vaccines | News | 0 Comment | 12 Sep, 2024
Looking ahead, BIOCHINA 2025 has officially announced its next conference, set for March 13-15, 2025. The 10th edition o...Read more
French firm Osivax grants rights to KM Biologics to develop and market influenza vaccine in Japan
Vaccines | News | 0 Comment | 10 Sep, 2024
Osivax, a FRance-based biopharmaceutical company developing vaccines to provide broad-spectrum protection against highly...Read more
Moderna’s COVID-19 mRNA vaccine targeting SARS-COV-2 Variant JN.1 receives approval in Taiwan
Vaccines | News | 0 Comment | 04 Sep, 2024
Moderna, Inc. has announced that the Taiwan Food & Drug Administration (FDA) has approved an updated formulation of ...Read more
mRNA as novel active ingredient – PlasmidFactory providing the template for tomorrow’s vaccines
Vaccines | News | By Ankit Kankar | ankit.kankar@mmactiv.com | 0 Comment | 02 Sep, 2024
Q: The usage of messenger RNA (mRNA) as novel active ingredient has attracted public attention in recent years, ...Read more
Bavarian Nordic receives approval of Smallpox and Mpox vaccine in Singapore
Vaccines | News | 0 Comment | 27 Aug, 2024
Danish firm Bavarian Nordic A/S has announced that Singapore’s medicines regulatory authority, Health Sciences Aut...Read more
New $3.3 M lab in Australia to design and manufacture cancer vaccines
Vaccines | News | 0 Comment | 29 Jul, 2024
A new facility at The University of Queensland (UQ) is set to provide Australian researchers with cancer vaccines tailor...Read more
Korea announces KRW 55 B funding for five years to develop vaccine storage technology, therapeutics
Vaccines | News | 0 Comment | 27 Jul, 2024
Korea's Ministry of Health and Welfare and the Korea Health Industry Development Institute (KHIDI) recent...Read more
Korea's SK bioscience invests $2 M in US biotech startup Sunflower Therapeutics
Vaccines | News | 0 Comment | 25 Jul, 2024
SK bioscience, a global innovative vaccine and biotech company based in South Korea, has signed a Simple Agreement for F...Read more